Transcatheter left atrial appendage closure for stroke prevention in atrial fi brillation with Amplatzer cardiac plug: The Belgian Registry

Acta Cardiologica

Volumn 68, Issue 6, 2013, Pages 551-558

  Kefer, Joëlle ^a   Vermeersch, Paul ^b   Budts, Werner ^c   Depotter, Tom ^d   Aminian, Adel ^e   Benit, Edouard ^f   Stammen, Francis ^g  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^b ZNA Middelheim   (Belgium)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^d OLV HOSPITAL   (Belgium)

^e Centre Hospitalier Universitaire de Charleroi   (Belgium)

^f Jessa Ziekenhuis   (Belgium)

^g Heilig Hart Roeselare   (Belgium)

Author keywords

Anticoagulant bleeding; Atrial fibrillation; Left atrial appendage; Stroke prevention

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; CLOPIDOGREL;

ADULT; AGED; AIR EMBOLISM; AMPLATZER VASCULAR PLUG; ARTICLE; BELGIUM; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; DEATH; DEVICE SAFETY; FALSE ANEURYSM; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART TAMPONADE; HUMAN; LEFT ATRIAL APPENDAGE CLOSURE DEVICE; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PERICARDIOCENTESIS; SCORING SYSTEM; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ATRIAL APPENDAGE; ATRIAL FIBRILLATION; BELGIUM; CARDIAC CATHETERIZATION; CARDIAC SURGICAL PROCEDURES; CINEANGIOGRAPHY; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REGISTRIES; SEPTAL OCCLUDER DEVICE; STROKE; TREATMENT OUTCOME;

EID: 84891649345     PISSN: 00015385     EISSN: 03737934     Source Type: Journal    
DOI: 10.1080/ac.68.6.8000001     Document Type: Article

References (27)

1. Go A, Halek E, Philips K, Chang Y, Henault L, Selby J, Singer D. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001; 285: 2370-5.
2. Crystal E, Connolly S. Role of oral anticoagulation in management of atrial fibrillation. Heart 2004; 90: 813-7.
3. Xu J, Kochanek K, Murphy S. Deaths: Final Data for 2007. NVSS 2010; 58: 1-136.
4. Rosamond W, Folsom A, Chambless L, Wang C, McGovern P, Howard G, Copper L, Shahar E. Stroke incidence and survival among middle-aged adults: 9-year follow-up of the Atherosclerosis Risk in Communities (ARIC) cohort. Stroke 1999; 30: 736-43.
5. Lamassa M, Di Carlo A, Pracucci G, Basile A, Trefoloni G, Vanni P, Spolveri S, Baruffi M, Landini G, Ghetti A, Wolfe C, Inzitari D. Characteristics, outcome, and care of stroke associated with atrial fibrillation in Europe. Stroke 2001; 32: 392-8.
6. Camm J, Lip G, De Caterina R, Savelieva I, Atar D, Hohnloser S, Hindricks G, Kirchhof P; ESC Committee for Practice Guidelines (CPG), Bax JJ, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Kirchhof P, Knuuti J, Kolh P, McDonagh T, Moulin C, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Torbicki A, Vahanian A, Windecker S; Document Reviewers, Vardas P, Al-Attar N, Alfieri O, Angelini A, Blömstrom-Lundqvist C, Colonna P, De Sutter J, Ernst S, Goette A, Gorenek B, Hatala R, Heidbüchel H, Heldal M, Kristensen SD, Kolh P, Le Heuzey JY, Mavrakis H, Mont L, Filardi PP, Ponikowski P, Prendergast B, Rutten FH, Schotten U, Van Gelder IC, Verheugt FW.
7. 2012 focused update of the ESC guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J 2012; 33: 2719-47.
8. Onalan O, Lashevsky I, Hamad A, Crystal E. Nonpharmacologic stroke prevention in atrial fibrillation. Exp Rev Cardiovasc Ther 2005; 3: 619-33.
9. Baker W, Cios D, Sander S, Coleman C. Meta-analysis to assess the quality of warfarin control in atrial fibrillation patients in the United States. J Manag Care Pharm 2009; 15: 244-52.
10. Connolly S, Ezekowitz M, Yusuf S, Eikelboom J, Oldgren J, Parekh A, Pogue J, Reilly P, Themeles E, Varrone J, Wang S, Alings M, Xavier D, Zhu J, Diaz R, Lewis B, Darius H, Diener H, Joyner C, Wallentin L; RE-LY Steering Committee and Investigators. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009; 361: 1139-51.
11. Patel M, Mahaffey K, Garg J, Pan G, Singer D, Hacke W, Breithardt G, Halperin J, Hankey G, Piccini J, Becker R, Nessel C, Paolini J, Berkowitz S, Fox K, Califf R; ROCKET AF Investigators. Rivaroxaban versus warfarin in atrial fibrillation. N Engl J Med 2011; 365: 883-91.
12. Granger C, Alexander J, McMurray J, Lopes R, Hylek E, Hanna M, Al-Khalidi H, Ansell J, Atar D, Avezum A, Bahit M, Diaz R, Easton J, Ezekowitz J, Flaker G, Garcia D, Geraldes M, Gersh B, Golistyn S, Goto S, Hermosillo A, Hohnloser S, Horowitz J, Mohan P, Jansky P, Lewis B, Lopez-Sendon J, Pais P, Parkhomenko A, Verheugt F, Zhu J, Wallentin L; ARISTOTLE Committees and Investigators. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 2011; 365: 981-92.
13. Alberg H. Atrial fibrillation: a study of atrial thrombus and systemic embolism in a necropsy material. Acta Med Scand 1969; 185: 373-9.
14. Klein A, Grimm R, Murray R, Apperson- Hansen C, Asinger R, Black I, Davidoff R, Erbel R, Halperin J, Orsinelli D, Porter T, Stoddard M. Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation. N Engl J Med 2001; 344: 1411-20.
15. Stollberger C, Schneider B, Finsterer J. Elimination of the left atrial appendage to prevent stroke or embolism? Anatomic, physiologic, and pathophysiologic considerations. Chest 2003; 124: 2356-62.
16. Healey J, Crystal E, Lamy A, Teoh K, Semelhago L, Hohnloser S, Cybulsky I, Abouzhar L, Sawchuck K, Carroll S, Morillo C, Kleine P, Chu V, Lonn E, Connolly S. Left atrial appendage occlusion study (LAAOS): results of a randomized controlled pilot study of left atrial appendage occlusion during coronary bypass surgery in patients at risk for stroke. Am Heart J 2005; 150: 288-93.
17. Bando K, Kobayashi J, Hirata M, Satoh T, Niwaya K, Tagusari O, Kakatani S, Yagihara T, Kitamura S. Early and late stroke after mitral valve replacement with a mechanical prosthesis: risk factor analysis of a 24-year experience. J Thorac Cardiovasc Surg 2003; 126: 358-64.
18. Sievert H, Lesh M, Trepels T, Omran H, Bartoelli A, Dela Bella P, Nakai T, Reisman M, DiMario C, Block P, Kramer P, Fleschenberg D, Krumsdorf U, Scherer D. Percutaneous left atrial appendage transcatheter occlusion to prevent stroke in high-risk patients with atrial fibrillation. Circ 2002; 105: 1887-9.
19. Block P, Burstein S, Casale P, Kramer P, Teirstein P, Williams D, Reisman D. Percutaneous left atrial appendage occlusion for patients in atrial fibrillation suboptimal for warfarin therapy: 5-year results of the PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) Study. JACC Cardiovasc Interv 2009; 2: 594-600.
20. Holmes D, Reddy V, Turi Z, Doshi S, Sievert H, Buchbinder M, Mullin C, Sick P; PROTECT AF investigators. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. Lancet 2009; 374: 534-42.
21. Park J-W, Bethencourt A, Sievert H, Santoro G, Meier B, Walsh K, Lopez-Minquez J, Meerkin D, Valdes M, Ormerod O, Leithauser B. Left atrial appendage closure with Amplatzer cardiac plug in atrial fibrillation: initial European experience. Catheter Cardiovasc Interv 2011; 77: 700-6.
22. Bass J. Transcatheter occlusion of the left atrial appendage --experimental testing of a new Amplatzer device. Catheter Cardiovasc Interv 2010; 76: 181-5.
23. Rodes-Cabau J, Champagne J, Bernier M. Transcatheter closure of the left atrial appendage: initial experience with the Amplatzer cardiac plug device. Catheter Cardiovasc Interv 2010; 76: 186-92.
24. Lopez-Minguez G, Eldoayen-Gragera J, Gonzalez-Fernandez R, Fernandez-Vegas C, Fuentes-Canamero M, Millan-Nunez V, Nogales-Asensio J, Martinez-Naharro A, Sanchez-Giralt S, Doblado-Calatrava M, Merchan-Herrera A. Immediate and one-year results in 35 consecutive patients after closure of left atrial appendage with the amplatzer cardiac plug. Rev Esp Cardiol 2013; 66: 90-7.
25. Reddy V, Holmes D, Doshi S, Neuzil P, Kar S. Safety of percutaneous left atrial appendage closure. Results from the Watchman Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) clinical trial and the Continued Access Registry. Circulation 2011; 123: 417-24.
26. Hanna I, Kolm P, Martin R, Reisman M, Gray W, Block P. Left atrial structure and function after percutaneous left atrial appendage transcatheter occlusion (PLAATO): six-month echocardiographic follow-up. J Am Coll Cardiol 2004; 43: 1868-72.
27. Reddy V, Doshi S, Sievert H, Buchbinder M, Neuzil P, Huber K, Halperin J, Holmes D; PROTECT AF Investigators. Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3 year follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients with Atrial Fibrillation) trial. Circulation 2013; 127: 720-9.